Mutant Colon Ca May Respond to BRAF-EGFR Inhibition (CME/CE)

(MedPage Today) — An unexpected feedback mechanism in cell signaling pathways may explain why some colorectal cancers don’t respond to a drug that theoretically should work, researchers reported.

Post a Comment

Comments are closed.